A Hybrid Satellite Symposium
Tuesday, June 7, 2022
12:45 PM – 1:45 PM EDT
Lunch will be provided
Sheraton Boston Hotel
Constitution Ballroom
39 Dalton Street, Boston, MA 02199
Also Available to Virtual Attendees via Online Simulcast
You must be registered for the American Transplant Congress 2022 to attend this symposium.
This symposium is not part of the ATC official educational program and the sessions and content are not endorsed by ATC.
FACULTY
Stanley C. Jordan, MD, FASN, FAST
Director, Nephrology & Transplant Immunology
Medical Director, Kidney Transplant Program
Cedars-Sinai Medical Center
Los Angeles, CA
Arjang Djamali, MD
Chair, Department of Medicine
Maine Medical Center
Portland, ME
Carrie A. Schinstock, MD
Associate Professor
Division of Nephrology and Hypertension
Mayo Clinic
Rochester, MN
Join us either in-person or virtually by simulcast, for the first ever Clinical OlympicsSM symposium! Attendees will join 1 of 3 countries/teams to compete in a series of clinical events, answering challenge questions on management of antibody-mediated rejection (AMR) in solid organ transplant (SOT) patients. Individual learners earn points for their chosen country by correctly answering questions during each event. After each event is completed, and at the conclusion of the overall symposium, a Team Leader Board appears on the big screens to show comparative scores across teams and a Gold, Silver, and Bronze medal will be awarded to countries for each event and for the entire Clinical OlympicsSM.
Renal transplantation is a potentially life-saving treatment for those with renal failure. However, graft rejection remains a problem, and long-term outcomes remain poor with about 40% of kidney transplants failing within 10 years. While chronic graft rejection is pathologically a multifactorial process, recent evidence indicates that chronic active AMR and the resulting transplant glomerulopathy are responsible for most cases, yet there are no approved therapies, which further complicates management. In this symposium, participants will join an esteemed panel to learn, in an interactive, gamified way, the pathophysiology of chronic active AMR, how to establish a diagnosis using histology and emerging biomarkers, and examine therapeutic options in the pipeline for chronic active AMR.
PROGRAM AGENDA
Stanley C. Jordan, MD, FASN, FAST
Understanding the Pathophysiology of Chronic Active AMR
Arjang Djamali, MD
Establishing a Definitive Histological Diagnosis of AMR
Carrie A. Schinstock, MD
Emerging Therapeutic Options for Chronic Active AMR
Stanley C. Jordan, MD, FASN, FAST
Stanley C. Jordan, MD, FASN, FAST
WHO SHOULD ATTEND?
This activity is intended for transplant, nephrology, and general surgery clinicians managing transplant patients with AMR.
LEARNING OBJECTIVES FOR ATTENDEES
Upon completion of this activity, participants should be better able to:
- Identify the pathophysiology of chronic active antibody-mediated rejection (AMR) that leads to deleterious clinical manifestations in kidney transplant patients
- Apply Banff diagnostic criteria for chronic active AMR in renal allografts
- Examine the potential role of emerging therapeutic approaches in the management of chronic active AMR
PROVIDER STATEMENT
This activity is provided by RMEI Medical Education, LLC.
SUPPORTER STATEMENT
This activity is supported by an independent educational grant from CSL Behring LLC.
ACCREDITATION
In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Physician Continuing Medical Education
RMEI Medical Education, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Financial Relationships
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. RMEI will disclose to learners the presence or absence of relevant financial relationships for all persons in control of content before the learner engages in the education.
Americans WIth Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact RMEI prior to the live event at (866) 770-RMEI.
FEE INFORMATION
There is no fee for this educational activity.
FOLLOW RMEI
Additional educational activities offered by RMEI Medical Education, LLC can be found
at www.RMEI.com or by calling toll-free (866) 770-RMEI.